Repligen Corp.(NASDAQ : RGEN)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||-0.02%||179.43||0.7%||$1295.65m|
|BMY||Bristol-Myers Squibb Co.||-2.36%||75.76||1.0%||$1183.57m|
|MRK||Merck & Co., Inc.||0.05%||92.36||0.7%||$1167.53m|
|LLY||Eli Lilly & Co.||1.66%||318.66||1.1%||$983.26m|
|BHVN||Biohaven Pharmaceutical Holding Co. Ltd.||0.19%||143.45||0.0%||$493.51m|
|HZNP||Horizon Therapeutics Plc||3.39%||93.67||5.4%||$202.69m|
|NVO||Novo Nordisk A/S||0.65%||107.29||0.1%||$184.04m|
Repligen Corp. provides bioprocessing technologies and solutions used in the process of manufacturing biologic drugs. It serves through the following product lines: Chromatography, Filtration, Process Analytics, and Proteins. The Chromatography product includes a range of products used in the downstream purification and quality control of biological drugs. The Filtration products offer a number of advantages to manufacturers of biologic drugs at volumes that span from pilot studies to clinical and commercial-scale production. The Process Analytics products complement and support filtration, chromatography and proteins in-line absorbance measurements allowing for the determination of protein concentration in filtration, chromatography formulation and fill-finish applications. The Proteins product franchise is represented by Protein A affinity ligands, which are a critical component of Protein A chromatography resins used in downstream purification of virtually all mAb-based drugs on the market. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.